

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 1 |
| Melanoma | D008545 | — | — | 1 | 1 | — | — | — | 1 |
| Neurofibrosarcoma | D018319 | — | — | 1 | 1 | — | — | — | 1 |
| Nerve sheath neoplasms | D018317 | EFO_0000760 | — | 1 | 1 | — | — | — | 1 |
| Uveal neoplasms | D014604 | EFO_1001230 | — | 1 | 1 | — | — | — | 1 |
| Point mutation | D017354 | — | — | 1 | 1 | — | — | — | 1 |
| Uveal melanoma | D000098943 | — | — | 1 | 1 | — | — | — | 1 |
| Drug common name | APG115 |
| INN | — |
| Description | Apg115 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CCN1[C@@H](C(=O)NC23CCC(C(=O)O)(CC2)CC3)[C@H](c2cccc(Cl)c2F)[C@]2(C(=O)Nc3cc(Cl)ccc32)C12CCCCC2 |
| PDB | — |
| CAS-ID | 1818393-16-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4091801 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |